U.S. National Vaccine Plan

U.S. National Vaccine Plan

The National Vaccine Plan was developed in 1994 by the Departments of Health and Human Services, Defense, and Veterans Affairs, and the U.S. Agency for International Development, and was coordinated by the National Vaccine Program Office (NVPO). The Plan describes the nation’s 10-year strategy for enhancing vaccine research and development, vaccine safety, informed decision-making by providers and the public, vaccine coverage and supply, and global health.

The 2008 draft strategic National Vaccine Plan, available below, was the initial step in updating the 1994 National Vaccine Plan. The process for updating the National Vaccine Plan included extensive opportunities for public engagement and comment to ensure the nation’s vaccine enterprise reflected the expertise and priorities of multiple stakeholders. The final strategic Plan will be released in early 2011.


Draft Documents

•2008 Draft Strategic National Vaccine Plan (PDF) (304KB)
http://www.hhs.gov/nvpo/vacc_plan/2008plan/draftvaccineplan.pdf


Public Comment

The National Vaccine Plan process offered many opportunities for public comment. Comments received in writing by March 31, 2009 are organized by section of the draft strategic National Vaccine Plan, and then by organization/individual. In keeping with the notices soliciting comments, which provided that all information would be made public, NVPO has listed the name of each organization and the author(s) of each set of comments. Federal Register notices soliciting comment are available here: Comments by January 30; extension to March 31.

•National Vaccines Plan Public Comments Summary (PDF) (169KB)
http://www.hhs.gov/nvpo/vacc_plan/orise_summary_report.pdf

•National Vaccine Plan Public Comments Table—Organizations (PDF) (588KB)
http://www.hhs.gov/nvpo/vacc_plan/nvppcommentsccommentstable.pdf


1994 National Vaccine Documents

•1994 National Vaccine Plan (ZIP - 34MB)
•1994 National Vaccine Plan by section


Public Engagement Activities

Public engagement activities are an important part of Plan development and revision. Comments and input from members of the public contribute to the draft strategic National Vaccine Plan. The National Vaccine Advisory Committee (NVAC), a federal advisory committee to HHS, is also involved in soliciting broad public input for the draft strategic Plan.

Approaches utilized for public and stakeholder input include:

•Written comments - submitted by interested individuals and organizations
•Institute of Medicine expert panel convened to engage stakeholders and review priorities
•Three all-day dialogues that included a cross-section of the general public from different communities
•A February 6, 2009 meeting of the NVAC with stakeholders


Institute of Medicine Review

HHS directed the National Academy of Sciences’ Institute of Medicine (IOM) to empanel an expert committee to assist in gathering stakeholder input. The committee reviewed the 1994 National Vaccine Plan and provided guidance on the development of the draft strategic Plan The IOM committee also held a series of national meetings focused around each of the goals that yielded important insights and perspectives from a diverse group of stakeholders.

On Dec. 11, 2009, the Institute of Medicine issued a report recommending priorities for the strategic National Vaccine Plan. The recommendations of the IOM will be considered as the Plan is finalized in 2010.

To access the report, please visit the IOM site: http://www.iom.edu/vaccineplan

•IOM Initial Guidance for an Update of the National Vaccine Plan
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office - Institute of Medicine


•IOM Review of National Vaccine Plan Priorities and Stakeholder Meeting Summaries
Review of Priorities in the National Vaccine Plan - Institute of Medicine



Community Dialogues

HHS representatives and the Oak Ridge Institute for Science and Education developed three public engagement meetings to solicit public input on the National Vaccine Plan. Public engagement meetings took place in St. Louis, Missouri on March 14, 2009; Columbus, Ohio on March 28, 2009; and Syracuse, New York on April 4, 2009. These locations were chosen in order to hear from people in different parts of the country and who may have different perspectives on vaccine and immunization issues.

The meetings included roughly 250 community members in total. Participants were sought through outreach from a variety of community networks, including health care providers, school-based and home-school-based organizations, alternative medicine providers, and the local media. Public meetings lasted a full day and included educational presentations, small group deliberations, and full group discussions. The primary objective was to identify participants’ values and concerns, which contributed to prioritization of scientific activities in the draft strategic National Vaccine Plan.

•Summary Report on the National Vaccine Plan Community Dialogs (PDF) (3.18MB)
•Citizen Voices on the National Vaccine Plan Presentation (PPT) (3.64MB)
Watch a video summary of the public meeting in Syracuse, NY.


NVAC Stakeholder Engagement - An Open Meeting

NVAC met in Washington, DC, on February 6, 2009, to hear the results of the public comments received on the Plan by January 30, and met with stakeholders in person and by teleconference. This information assisted their deliberations and recommendations on the draft Plan. The meeting was open to the public and offered significant opportunity for public comment.

Summaries of the February 6, 2009 breakout sessions and lists of participants are available below:

•Goal 1: Develop new and improved vaccines (PDF) (23KB)
•Goal 2: Enhance the safety of vaccines and vaccination practices (PDF) (29KB)
•Goal 3: Support informed vaccine decision-making by the public, providers, and policy-makers (PDF) (14KB)
•Goal 4: Ensure a stable supply of recommended vaccines and achieve better use of existing vaccines to prevent disease, disability and death in the United States (PDF) (23KB)
•Goal 5: Increase global prevention of death and disease through safe and effective vaccination (PDF) (18KB)
•Vaccine Industry and Researchers (PDF) (18KB)
•Healthcare Professional Organizations (PDF) (2KB)
•Health Care Payers (PDF) (17KB)
•Public Health Organizations (PDF) (19KB)


HHS Commitment to Conversation

HHS is committed to obtaining broad public input on vaccines and the immunization enterprise. Since 2000, HHS has sponsored public and stakeholder engagement meetings on vaccine issues, including a session on pandemic influenza to consider priorities for vaccination, community strategies, and protecting vulnerable populations. HHS will seek further opportunities to build trust and transparency in vaccination program policy through additional public outreach.

Comments or questions about the draft Plan should be directed to the National Vaccine Program Office at NVPComments@hhs.gov.

U.S. National Vaccine Plan


U.S. National Vaccine Plan